<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04042454</url>
  </required_header>
  <id_info>
    <org_study_id>EBB18TA19425</org_study_id>
    <nct_id>NCT04042454</nct_id>
  </id_info>
  <brief_title>To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation</brief_title>
  <acronym>Solar</acronym>
  <official_title>A Randomized, Controlled Study to Evaluate the Safety and Tolerance of an Infant Formula With Locust Bean Gum in Infants With Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, controlled study to evaluate the safety and tolerance of an infant formula with
      locust bean gum in infants with regurgitation. (Solar)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average stool consistency</measure>
    <time_frame>8 weeks</time_frame>
    <description>The average stool consistency (based on the 4-point Brussels Infant and Toddler Stool Scale [BITSS]) of the 8th week of intervention, adjusted for the baseline stool consistency score. Catagories are hard stools, formed stools, loose stools and watery stools. https://bitss-stoolscale.com/ (assessed 31-Jan-19) can be used as a further reference.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Regurgitation, Gastric</condition>
  <arm_group>
    <arm_group_label>Test Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cow's milk-based infant formula containing the thickener locust bean gum containing prebiotic oligosaccharides and postbiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cow's milk-based infant formula containing prebiotic oligosaccharides and postbiotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>milk based anti-regurgitation infant formula</intervention_name>
    <description>Cow's milk-based infant formula containing the thickener locust bean gum containing prebiotic oligosaccharides and postbiotics</description>
    <arm_group_label>Test Product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk based infant formula</intervention_name>
    <description>Cow's milk-based infant formula containing prebiotic oligosaccharides and postbiotics</description>
    <arm_group_label>Control Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Singleton infants with regurgitation who are otherwise healthy

          2. Diagnosed with regurgitation according to the (adapted) Rome IV diagnostic criteria.

          3. Term infants with a gestational age at birth of ≥37 weeks + 0 days and ≤41 weeks + 6
             days

          4. Aged &gt; 3 weeks (21 days) and &lt; 9 weeks (63 days) at screening

          5. Exclusively formula fed for ≥ 7 days before screening

          6. Written informed consent from the parent(s) and/or legally acceptable
             representative(s)

        Exclusion Criteria:

          1. Low birth weight for gestational age and gender

          2. Infants diagnosed with or suspected to have gastroesophageal reflux disease (GERD). I

          3. Infants who received any of the following medication within 4 weeks prior to
             screening: systemic antibiotics, prokinetics and/or proton pump inhibitors and/or
             (other) medication to treat regurgitation

          4. Infants who already consumed a thickened anti-regurgitation (AR) formula or used
             thickening supplements

          5. Infants who already started complementary feeding

          6. Infants with a gastrointestinal infection within 4 weeks prior to screening

          7. Infants with a congenital condition, previous or current illness, and/or medication
             use that could interfere with the main study outcomes according to the investigator

          8. Infants known or suspected to have: allergy for fish, soy protein, soy oil or corn;
             lactose intolerance; galactosaemia including history of any other allergic
             manifestations or known allergy to any of the study product ingredients and/or
             requiring a fibre-free diet

          9. Infants known or suspected to have allergy to cow's milk protein

         10. Presence of any other gastrointestinal symptom(s)/disorder(s) that are not functional
             in nature, as assessed by the investigator's clinical judgement

         11. Participation in any other studies involving investigational or marketed products
             concomitantly or prior to screening

         12. Incapability of the parent(s) to comply with the study protocol or investigator's
             uncertainty about the willingness or ability of the parent(s) to comply with the
             protocol requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>9 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gerda Gerda van Wijhe</last_name>
    <phone>+31302095000</phone>
    <email>gerda.vanwijhe@danone.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Poliklinika Ginekologiczno-Położnicza Sp. z o.o. Sp. k.</name>
      <address>
        <city>Białystok</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bartosz Kasprzaka</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>August 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Laryngopharyngeal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

